Skip to content

Cleerly Awarded Best Use of AI in Health Tech


Cleerly, a digital healthcare company offering artificial-intelligence-based software to identify and measure atherosclerosis from Coronary Computed Tomography Angiography (CCTA) imaging tests, was awarded Best in Class for the Best Use of AI in Health Tech at the 2023 Digital Health Hub Foundation Awards.

The Digital Health Hub Foundation Awards recognizes the achievements of innovative health tech companies that are dramatically improving healthcare through the use of technology in the digital health industry in two tracks and 13 categories.”  The Best Use of AI in Health Tech Award focuses on those healthcare innovations utilizing AI in a way that is reliable, cost-efficient, and an improvement to a patient’s quality of care.

More than 1,500 companies applied for a 2023 Digital Health Hub Foundation Award, with 350 qualifying as quarterfinalists and 127 qualifying as finalists.  Only one of the 127 finalists earned “Best in Class” in each of the 13 categories.  In addition to the several criteria the Digital Health Hub Foundation uses to select its quarter finalists and finalists, the three criteria for selecting each Best in Class award are: (1) the scope of the problem the company’s innovation seeks to solve; (2) the impact of the innovation, and (3) the innovation’s differentiation from competitors.

Cleerly owes its Best in Class Award to a “digital care pathway” that utilizes an AI algorithm to analyze images of a person’s arteries, thus facilitating early diagnosis and tracking of coronary heart disease.  Specifically, a CCTA imaging test provides noninvasive three-dimensional imaging of a person’s arteries.   Cleerly’s AI algorithm then identifies, quantifies, and categorizes plaque in a patient’s arteries, as well as locates and quantifies stenoses of the arteries.  Based on this data, the algorithm describes the patient’s plaque content based on a four-tiered system—i.e., “no plaque,” “mild plaque,” “moderate plaque,” and “severe plaque”—that can be used by a healthcare professional to guide patient treatment.

“By improving the detection of actionable heart health issues, we are continuing to forward our mission of creating a society free from heart attacks,” stated founder and CEO of Cleerly, James K. Min, in Cleery’s press release about the award.  “We are honored that The Digital Health Hub Foundation recognizes the value of our groundbreaking work.”


, , , , , , , ,

Cleerly Awarded Best Use of AI in Health Tech Headshot

Adam Copeland

Adam Copeland is an associate based in the firm's San Diego office.

Adam graduated cum laude from Washington University School of Law in St. Louis in 2022, and graduated summa cum laude with a B.S. in physics from Montana State University in 2019. While in law school, Adam primarily enjoyed engaging with first-year law students as a legal writing teaching assistant, helping them hone their skills in factual analysis and legal writing. Adam was also fortunate to have worked closely for two federal judges during law school: once as an intern for the Honorable Roseann A. Ketchmark in the Western District of Missouri, and once as an extern for the Honorable Nancy J. Rosenstengle in the Southern District of Illinois.

While serving as primary editor of the Washington University Global Studies Law Review, Adam received a Mary Collier Hitchcock prize for outstanding writing for his note regarding the problem of—and potential solutions to—frivolous lawsuits filed in the intellectual property field.

Adam joined the firm in 2022.

View all posts published by Adam Copeland
By using this blog, you agree and understand that no information is being provided in the context of any attorney-client relationship. You further agree and understand that nothing herein is intended to be legal advice. This blog is solely informational in nature, and is not intended as, and should not be used as, a substitute for competent legal advice from a retained and licensed attorney in your state. Knobbe Martens LLP makes no representations or warranties as to the accuracy, completeness, timeliness or availability of the information in this blog. Knobbe Martens LLP will not be liable for any injury or damages relating to your use of, or access to, any such information. Knobbe Martens LLP undertakes no obligation to correct or update information on this blog, which may be incorrect or become incorrect or out of date over time. Knobbe Martens LLP reserves the right to alter or delete content or information on the blog at any time. This blog contains links and references to other websites and publications that you may find of interest. Knobbe Martens LLP does not control, promote, endorse or otherwise have any affiliation with any other websites or publications unless those websites or publications expressly state such an affiliation. Knobbe Martens LLP further has no responsibility for, and makes no representations regarding, the content, accuracy or any other aspect of the information in such websites or publications.
close modal